GAD antibodies in neurological disorders — insights and challenges | Nature Reviews Neurology
GAD antibody-spectrum disorders: progress in clinical phenotypes, immunopathogenesis and therapeutic interventions - Popianna Tsiortou, Harry Alexopoulos, Marinos C. Dalakas, 2021
Should anti-glutamic acid decarboxylase antibody levels be determined in new-onset diabetes? - Endocrine Practice
e change in irisin level in type 1 diabetes mellitus patients according... | Download Scientific Diagram
Presence of anti-GAD in a non-diabetic population of adults; time dynamics and clinical influence: results from the HUNT study
Clinical Characteristics, Residual Beta-Cell Function and Pancreatic Auto- Antibodies in Thai people with Long-Standing Type 1 Diabetes Mellitus | Journal of the ASEAN Federation of Endocrine Societies
GAD antibodies and diabetes: What's the connection?
The Role of the Antigen GAD 65 in Diabetes Mellitus Type 1: A Molecular Analysis | IntechOpen
IJMS | Free Full-Text | Neurological Syndromes Associated with Anti-GAD Antibodies
Anti-GAD levels of patients who had an episode of diabetic ketoacidosis | Download Table
Pro- and anti-inflammatory response in neurological disorders associated to anti-glutamate decarboxylase antibodies - ScienceDirect
Autoantigen Based Vaccines for Type 1 Diabetes - Dequina Nicholas - Discovery Medicine
A Novel Subtype of Type 1 Diabetes Mellitus Characterized by a Rapid Onset and an Absence of Diabetes-Related Antibodies | NEJM
Detection of anti-glutamic acid decarboxylase 65 (GAD65) antibodies in... | Download Scientific Diagram
AWAF | Bristol Medical School: Translational Health Sciences | University of Bristol
Prevalence of anti-GAD in different populations. | Download Scientific Diagram
NAA Services for Anti-GAD65 - Creative Biolabs
Pancreatic autoantibodies: who to test and how to interpret the results - Misra - 2017 - Practical Diabetes - Wiley Online Library
Glutamate Decarboxylase - an overview | ScienceDirect Topics
GAD antibody-spectrum disorders | MedLink Neurology
Adult-onset autoimmune diabetes identified by glutamic acid decarboxylase autoantibodies: a retrospective cohort study | SpringerLink
GAD antibodies in neurological disorders — insights and challenges | Nature Reviews Neurology
